Covid-19 Update Debate
Full Debate: Read Full DebateLord Mackenzie of Framwellgate
Main Page: Lord Mackenzie of Framwellgate (Non-affiliated - Life peer)Department Debates - View all Lord Mackenzie of Framwellgate's debates with the Department of Health and Social Care
(3 years, 5 months ago)
Lords ChamberMy Lords, on lateral flow tests, I said that I did not recognise the press reports that the noble Baroness mentioned, and I still do not. On shielding, I completely agree with noble Lord. Some 1.5 million patients are identified as CEV-equivalent through the new QCovid model, and they have been added to the shielding patient list, with 820,000 who had not previously been invited as part of the JCVI cohorts 1 to 4 given priority access to vaccines. Overall, 3.8 million—I think I said 3.5 million earlier—individuals are on the shielded patient list, and we continue to maintain that through the NHS. We will look at the QCovid model and see if we can apply mix-and-match vaccines, booster shots and third shots to that model, and if we can bring together a new risk assessment for those who are vulnerable. That list could therefore be applied to any future shielding or protection that may be needed.
My Lords, I ask the noble Lord the Minister, in his usual courteous and helpful manner at the Dispatch Box, to provide answers to points raised yesterday with the Prime Minister in another place. In his usual way, the Prime Minister answered by asking yet another question, which of course earned another rebuke from the Speaker. If infections are allowed to rise, perhaps to 100,000 per day, how much are hospital admissions likely to increase and how many deaths may result? Why are the changes regarding isolation not taking effect until 16 August, with all the disruption to businesses in the interim?
The bottom line is that we believe that any rise in the infection rate will not have an impact on hospitalisation in a way that will disrupt the NHS. This is something that we have worked on with NHS colleagues, the clinical directors, the CMO’s office and the JBC, and we have taken into account a large variety of advice, including from SAGE. At the end of the day, it is our belief that, despite the rise of a third wave, hospitalisation rates will be manageable.